This Contemporary OB/GYN® supplement addresses effective screening for and appropriate treatment of tuberculosis (TB) by identifying high-risk subsets both for acquiring an infection and transitioning from latent to active TB, comparing two primary screening methods, and examining treatment regimens for active and latent infections.
Making Sense of TB Testing Guidelines
Stephanie Ros, MD, MSCI, discusses her criteria for testing, including social, institutional and vaccination history; as well as place of origin and prior diagnosis. Dr. Ros also reviews advantages of the interferon gamma release assay as a screening method and suggests next steps for patients testing positive.
Presented by: Stephanie Ros, MD, MSCI
Stephanie Ros, MD, MSCI, is a high-risk pregnancy specialist with focuses on teaching, labor and birth, genetics, and helping patients who have experienced pregnancy loss. As an assistant residency program director, Dr. Ros supervises fellows, residents, and medical students.
Tuberculosis Screening 101: A Primer
Though easily screened for, prevented and treated, tuberculosis is a leading cause of non-obstetrical death worldwide in reproductive age women, and significantly increases risk of maternal and fetal morbidity and mortality.
In this Contemporary OB/GYN® podcast, Lee P. Shulman, MD, FACMG, FACOG, discusses screening selectivity to reach high-risk populations, advantages of using an in-vitro blood test based on interferon-gamma release assay over a skin test with purified protein derivative, and appropriate treatment steps for patients testing positive.
Presented by: Lee P. Shulman, MD, FACMG, FACOG
Lee P. Shulman MD is the Anna Ross Lapham Professor in Obstetrics and Gynecology in the Division of Clinical Genetics at the Feinberg School of Medicine at Northwestern University in Chicago, Illinois. He also serves as the Medical Director of Insight Medical Genetics and Reproductive Genetics Innovations. Dr. Shulman is an Adjunct Professor in the Department of Medicinal Chemistry and Pharmacognosy at the University of Illinois at Chicago College of Pharmacy. A Fellow of the American College of Obstetricians and Gynecologists and a Founding Fellow of the American College of Medical Genetics, Dr. Shulman is a member of numerous regional, national and international organizations that pertain to the health and care of women and families. His work has been recognized regionally and nationally; most recently, he was again included in the list of “Top Doctors” in Chicago (2007-20) and America (2005-20). Dr. Shulman served as Chair of the Board of Trustees of the Association of Reproductive Health Professionals from 2006-2008, is a Past President of the Central Association of Obstetricians and Gynecologists and the current Chair of the Fetoscopy Working Group. A frequent contributor to the peer-reviewed and informational literature with over 200 peer-reviewed articles and 60 book chapters, Dr. Shulman’s major research interests are in reproductive and cancer genetics, contraception and reproductive medicine, menopause, women’s healthcare advocacy and botanical interventions in women’s health.
